8968752

Information

• Patent Grant
• 8968752

• References
• Source

• Patent Number

  8,968,752

• Date Filed

  Not available

• Date Issued

  Tuesday, March 3, 2015
  10 years ago

• CPC

  • A61K9/146 - with organic macromolecular compounds
  • A61K9/0019 - Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
  • A61K9/5169 - Proteins
  • A61K31/165 - having aromatic rings
  • A61K31/282 - Platinum compounds
  • A61K31/337 - having four-membered rings
  • A61K31/395 - having nitrogen as a ring hetero atom
  • A61K31/436 - the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e..g. rapamycin
  • A61K31/517 - ortho- or peri-condensed with carbocyclic ring systems
  • A61K31/519 - ortho- or peri-condensed with heterocyclic rings
  • A61K31/5377 - not condensed and containing further heterocyclic rings
  • A61K31/555 - containing heavy metals
  • A61K31/675 - having nitrogen as a ring hetero atom
  • A61K31/69 - Boron compounds
  • A61K31/704 - attached to a condensed carbocyclic ring system
  • A61K31/7068 - having oxo groups directly attached to the pyrimidine ring
  • A61K31/7072 - having two oxo groups directly attached to the pyrimidine ring
  • A61K33/24 - Heavy metals Compounds thereof
  • A61K38/16 - Peptides having more than 20 amino acids Gastrins Somatostatins Melanotropins Derivatives thereof
  • A61K38/38 - Albumins
  • A61K39/39558 - against tumor tissues, cells, antigens
  • A61K45/06 - Mixtures of active ingredients without chemical characterisation
  • A61K47/42 - Proteins Polypeptides Degradation products thereof Derivatives thereof
  • A61K47/48284 - the peptide or protein in the drug conjugate being an albumin
  • A61K47/48892 - the material constituting the nanoparticle being a polymer
  • A61N5/10 - X-ray therapy Gamma-ray therapy Particle-irradiation therapy